UNIT 1, Pharmacology RNSG 1301 EPCC EXAM 1
QUESTIONS WITH CORRECT ANSWERS
1. |A |nurse |is |assessing |the |client's |home |medication |use. |After |listening |to |the |client |list |
current |medications, |the |nurse |asks |what |priority |question?
A) |"Do |you |take |any |generic |medications?"
B) |"Are |any |of |these |medications |orphan |drugs?"
C) |"Are |these |medications |safe |to |take |during |pregnancy?"
D) |"Do |you |take |any |over-the-counter |medications?" |- |CORRECT |ANSWER✔✔-D) |"Do |you |take |
any |over-the-counter |medications?"
2. |Which |classification |applies |to |Morphine?
A) |central |nervous |system |depressant
B) |central |nervous |system |stimulant
C) |anti-inflammatory
D) |antihypertensive |- |CORRECT |ANSWER✔✔-A) |central |nervous |system |depressant
3. |While |studying |for |the |test, |a |nursing |student |encounters |the |following |drug: |ibuprofen |
(Motrin). |What |does |the |nursing |student |identify |the |name |ibuprofen |as?
A) |The |generic |name
B) |The |chemical |name
C) |The |brand |name
,D) |The |chemical |and |generic |name |- |CORRECT |ANSWER✔✔-A) |The |generic |name
4. |A |nurse |is |teaching |the |client |about |the |use |of |over |the |counter |(OTC) |drugs. |Which |
statement |best |informs |the |client |about |their |use?
A) |"OTC |drugs |are |products |that |are |available |without |prescription |for |self-treatment |of |minor |
health |issues."
B) |"OTC |drugs |are |considered |medication |and |should |be |reported |on |a |drug |history."
C) |"OTC |drugs |were |approved |as |prescription |drugs |but |later |were |found |to |be |safe |without |
the |need |of |a |prescription."
D) |"OTC |drugs |need |to |be |taken |with |caution; |they |can |mask |the |signs |and |symptoms |of |an |
underlying |disease |and |interfere |with |prescription |drug |therapy." |- |CORRECT |ANSWER✔✔-D)
|"OTC |drugs |need |to |be |taken |with |caution; |they |can |mask |the |signs |and |symptoms |of |an |
underlying |disease |and |interfere |with |prescription |drug |therapy."
5. |Which |term |is |used |to |describe |the |study |of |drugs |and |their |action |on |living |organism?
A) |Pharmacology
B) |Microbiology
C) |Biology
D) |Pharmacotherapeutics |- |CORRECT |ANSWER✔✔-A) |Pharmacology
6. |A |health |care |facility |is |complying |with |the |mandates |of |The |Drug |Enforcement |
Administration |(DEA) |concerning |Schedule |II |medications |when |implementing |which |nursing |
intervention? |Select |all |that |apply.
A) |Assess |to |narcotics |is |controlled |by |key |or |codes.
B) |Narcotics |are |administered |by |prescriptions |only.
C) |Only |selected |narcotics |may |be |automatically |renewed.
,D) |The |administration |of |individual |narcotic |doses |are |recorded |in |specific |unit |documentation.
E) |Any |recognized |discrepancy |involving |a |narcotic |must |be |reported |to |the |appropriate |facility
|authority. |- |CORRECT |ANSWER✔✔-A) |Assess |to |narcotics |is |controlled |by |key |or |codes.
B) |Narcotics |are |administered |by |prescriptions |only.
D) |The |administration |of |individual |narcotic |doses |are |recorded |in |specific |unit |documentation.
E) |Any |recognized |discrepancy |involving |a |narcotic |must |be |reported |to |the |appropriate |facility
|authority.
7.Which |organization |is |responsible |for |approving |new |drugs |in |the |United |States?
A) |American |Medical |Association |(AMA)
B) |American |Pharmaceutical |Association |(APA)
C) |Food |and |Drug |Administration |(FDA)
D) |United |States |Pharmacopeia |- |CORRECT |ANSWER✔✔-C) |Food |and |Drug |Administration |
(FDA)
8. |A |nursing |student |in |a |pharmacology |class |should |be |encouraged |to |study |the |medications |
according |to |which |categorization? |Select |all |that |apply.
A) |prototype
B) |controlled |substance
C) |drug |use
D) |generic |names
E) |therapeutic |classification |- |CORRECT |ANSWER✔✔-A) |prototype
E) |therapeutic |classification
, 9. |A |client |is |confused |and |has |stated |to |the |nurse, |"I |wasn't |sure |whether |I'm |supposed |to |
take |Tylenol |or |acetaminophen." |To |best |address |the |client's |concern, |the |nurse |should |base |
the |response |on |what |information |concerning |generic |and |trade |names?
A) |Prescribers |should |refer |solely |to |generic |names |in |their |recommendations |and |written |
prescriptions.
B) |A |generic |name |is |independent |of |any |particular |drug |manufacturer.
C) |Generic |names |change |frequently, |but |trade |names |are |more |consistent.
D) |Prescribers |should |refer |solely |to |trade |names |in |their |recommendations |and |written |
prescriptions |- |CORRECT |ANSWER✔✔-B) |A |generic |name |is |independent |of |any |particular |drug
|manufacturer.
10. |A |client's |current |medication |administration |record |includes |a |drug |that |the |nurse |
recognizes |as |an |Institute |for |Safe |Medication |Practices |(ISMP) |high-alert |medication. |This |
designation |signals |the |nurse |to |what |characteristic |of |the |drug?
A) |It |can |only |be |administered |by |a |health |care |provider |or |advanced |practice |nurse.
B) |Administration |must |be |cosigned |by |a |second |registered |nurse |or |practical/vocational |
nurse.
C) |It |is |currently |undergoing |Phase |4 |testing |and |is |pending |full |FDA |approval.
D) |Administration |errors |carry |a |heightened |risk |of |causing |significant |client |harm. |- |CORRECT |
ANSWER✔✔-D) |Administration |errors |carry |a |heightened |risk |of |causing |significant |client |
harm.
11. |A |hospital |nurse |is |vigilant |in |ensuring |the |safe |use |of |medications |and |consistently |applies
|the |rights |of |medication |administration. |What |are |the |rights |of |medication |administration? |
Select |all |that |apply.
A) |right |to |refuse |prescribed |medication
B) |right |route |for |effective |medication |therapy
QUESTIONS WITH CORRECT ANSWERS
1. |A |nurse |is |assessing |the |client's |home |medication |use. |After |listening |to |the |client |list |
current |medications, |the |nurse |asks |what |priority |question?
A) |"Do |you |take |any |generic |medications?"
B) |"Are |any |of |these |medications |orphan |drugs?"
C) |"Are |these |medications |safe |to |take |during |pregnancy?"
D) |"Do |you |take |any |over-the-counter |medications?" |- |CORRECT |ANSWER✔✔-D) |"Do |you |take |
any |over-the-counter |medications?"
2. |Which |classification |applies |to |Morphine?
A) |central |nervous |system |depressant
B) |central |nervous |system |stimulant
C) |anti-inflammatory
D) |antihypertensive |- |CORRECT |ANSWER✔✔-A) |central |nervous |system |depressant
3. |While |studying |for |the |test, |a |nursing |student |encounters |the |following |drug: |ibuprofen |
(Motrin). |What |does |the |nursing |student |identify |the |name |ibuprofen |as?
A) |The |generic |name
B) |The |chemical |name
C) |The |brand |name
,D) |The |chemical |and |generic |name |- |CORRECT |ANSWER✔✔-A) |The |generic |name
4. |A |nurse |is |teaching |the |client |about |the |use |of |over |the |counter |(OTC) |drugs. |Which |
statement |best |informs |the |client |about |their |use?
A) |"OTC |drugs |are |products |that |are |available |without |prescription |for |self-treatment |of |minor |
health |issues."
B) |"OTC |drugs |are |considered |medication |and |should |be |reported |on |a |drug |history."
C) |"OTC |drugs |were |approved |as |prescription |drugs |but |later |were |found |to |be |safe |without |
the |need |of |a |prescription."
D) |"OTC |drugs |need |to |be |taken |with |caution; |they |can |mask |the |signs |and |symptoms |of |an |
underlying |disease |and |interfere |with |prescription |drug |therapy." |- |CORRECT |ANSWER✔✔-D)
|"OTC |drugs |need |to |be |taken |with |caution; |they |can |mask |the |signs |and |symptoms |of |an |
underlying |disease |and |interfere |with |prescription |drug |therapy."
5. |Which |term |is |used |to |describe |the |study |of |drugs |and |their |action |on |living |organism?
A) |Pharmacology
B) |Microbiology
C) |Biology
D) |Pharmacotherapeutics |- |CORRECT |ANSWER✔✔-A) |Pharmacology
6. |A |health |care |facility |is |complying |with |the |mandates |of |The |Drug |Enforcement |
Administration |(DEA) |concerning |Schedule |II |medications |when |implementing |which |nursing |
intervention? |Select |all |that |apply.
A) |Assess |to |narcotics |is |controlled |by |key |or |codes.
B) |Narcotics |are |administered |by |prescriptions |only.
C) |Only |selected |narcotics |may |be |automatically |renewed.
,D) |The |administration |of |individual |narcotic |doses |are |recorded |in |specific |unit |documentation.
E) |Any |recognized |discrepancy |involving |a |narcotic |must |be |reported |to |the |appropriate |facility
|authority. |- |CORRECT |ANSWER✔✔-A) |Assess |to |narcotics |is |controlled |by |key |or |codes.
B) |Narcotics |are |administered |by |prescriptions |only.
D) |The |administration |of |individual |narcotic |doses |are |recorded |in |specific |unit |documentation.
E) |Any |recognized |discrepancy |involving |a |narcotic |must |be |reported |to |the |appropriate |facility
|authority.
7.Which |organization |is |responsible |for |approving |new |drugs |in |the |United |States?
A) |American |Medical |Association |(AMA)
B) |American |Pharmaceutical |Association |(APA)
C) |Food |and |Drug |Administration |(FDA)
D) |United |States |Pharmacopeia |- |CORRECT |ANSWER✔✔-C) |Food |and |Drug |Administration |
(FDA)
8. |A |nursing |student |in |a |pharmacology |class |should |be |encouraged |to |study |the |medications |
according |to |which |categorization? |Select |all |that |apply.
A) |prototype
B) |controlled |substance
C) |drug |use
D) |generic |names
E) |therapeutic |classification |- |CORRECT |ANSWER✔✔-A) |prototype
E) |therapeutic |classification
, 9. |A |client |is |confused |and |has |stated |to |the |nurse, |"I |wasn't |sure |whether |I'm |supposed |to |
take |Tylenol |or |acetaminophen." |To |best |address |the |client's |concern, |the |nurse |should |base |
the |response |on |what |information |concerning |generic |and |trade |names?
A) |Prescribers |should |refer |solely |to |generic |names |in |their |recommendations |and |written |
prescriptions.
B) |A |generic |name |is |independent |of |any |particular |drug |manufacturer.
C) |Generic |names |change |frequently, |but |trade |names |are |more |consistent.
D) |Prescribers |should |refer |solely |to |trade |names |in |their |recommendations |and |written |
prescriptions |- |CORRECT |ANSWER✔✔-B) |A |generic |name |is |independent |of |any |particular |drug
|manufacturer.
10. |A |client's |current |medication |administration |record |includes |a |drug |that |the |nurse |
recognizes |as |an |Institute |for |Safe |Medication |Practices |(ISMP) |high-alert |medication. |This |
designation |signals |the |nurse |to |what |characteristic |of |the |drug?
A) |It |can |only |be |administered |by |a |health |care |provider |or |advanced |practice |nurse.
B) |Administration |must |be |cosigned |by |a |second |registered |nurse |or |practical/vocational |
nurse.
C) |It |is |currently |undergoing |Phase |4 |testing |and |is |pending |full |FDA |approval.
D) |Administration |errors |carry |a |heightened |risk |of |causing |significant |client |harm. |- |CORRECT |
ANSWER✔✔-D) |Administration |errors |carry |a |heightened |risk |of |causing |significant |client |
harm.
11. |A |hospital |nurse |is |vigilant |in |ensuring |the |safe |use |of |medications |and |consistently |applies
|the |rights |of |medication |administration. |What |are |the |rights |of |medication |administration? |
Select |all |that |apply.
A) |right |to |refuse |prescribed |medication
B) |right |route |for |effective |medication |therapy
